- The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysister Veer Emil; Mohammad Nadia Haj; Lodder Paul; Ngai Lok Lam; Samaan Mary; van Oijen Martijn G H; van Laarhoven Hanneke W MGastric Cancer, 2016, 19(3): 696-712.
- Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecanKang Byung Woog; Kim Jong Gwang; Kwon Oh Kyoung; Chung Ho Young; Yu WansikWorld Journal of Gastroenterology, 2014, 20(18): 5396-5402.
- Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trialsHuang Jun; Zhao Yongzhao; Xu Yong; Zhu Yanjie; Huang Jiale; Liu Yanna; Zhao Liying; Li Zhijia; Liu Hao; Wang Qi long; Qi XiaolongONCOTARGET, 2016, 7(23): 34824-34831.
期刊论文
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
13阅读
